SEARCH RESULTS FOR: "Tag: XBI"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(2)
2018(5)
2017(14)
2016(5)
2015(1)
CATEGORIES
5-Minute Market Rundown(1)
Bernie's Content(2)
Best and Worst Stocks(4)
By the Numbers(1)
Editor's Pick(1)
Expectational Analysis(1)
Indexes and ETFs(15)
Indicator of the Week(1)
Intraday Option Activity(11)
Quantitative Analysis(6)
Stock Market News(6)
Stocks On the Move(3)
Technical Analysis(2)
Unusual Trading Activity(1)

3/4/2019 9:44 AM
The technical breakout last week in the SPDR S&P Biotech ETF (XBI) was remarkable, by any number of measures. After a 3% opening gap to start Monday's session, the small-cap biotech-focused exchange-...
1/23/2019 2:46 PM
It's turning out to be a down day for drug stocks, as the SPDR S&P Biotech ETF (XBI) trades down 1.8% at $79.43. In the meantime, one options trader is putting their money behind a three-way bearish ...
11/6/2018 2:30 PM
Midterm elections are taking place across the U.S. today, as you're likely well aware. Last week, we took a broader look at the impact of these mid-cycle votes on stocks. This week, with expectations...
7/17/2018 7:34 AM
As we head into July options expiration week, there's no shortage of catalysts -- both micro and macro -- to drive major stock market moves. Not only are we heading into the thick of second-quarter ea...
5/18/2018 1:36 PM
Many of the top losers on the Nasdaq today are biotech stocks, and options data on the SPDR S&P Biotech ETF (XBI) suggests at least one trader is confident more downside is ahead in the coming weeks....

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center